NuChem Sciences Company Profile: Funding & Investors

NuChem Sciences Overview

Founded
2011

Status
Private

Employees
83

Latest Deal Type
PE Growth

Financing Rounds
3

Investments
2

NuChem Sciences General Information

Description

Provider of medical contract research services intended to identify and optimize pre-clinical candidates in the area of small molecule drug discovery. The company's services specialize in the field of medicinal chemistry, drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship design, computational drug design, enabling international biotech and pharmaceuticals industries to move their project forward quickly and efficiently.

Contact Information

Website

www.nuchemsciences.com

Ownership Status

Privately Held (backing)

Financing Status

Private Equity-Backed

Primary Industry

Biotechnology

Other Industries

Practice Management (Healthcare)

Discovery Tools (Healthcare)

Primary Office

2350 rue Cohen
Suite 201
Saint-Laurent, Quebec H4R 2N6
Canada

+1 (514) 000-0000







Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuChem Sciences Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore NuChem Sciences‘s full profile, request access.

Request a free trial

NuChem Sciences Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Provider of medical contract research services intended to identify and optimize pre-clinical candidates in the area of

Biotechnology

Saint-Laurent, Canada

83 As of 2021

0000

000 0000-00-00

0000000 0000 0000

000 0000

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis

00000000 0000000000 (0000000000)

Covington, KY

0000 As of 0000

000000000 -

00000000

liquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillu

0000000000000

Cuxhaven, Germany

00 As of 0000

000000000000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NuChem Sciences Competitors (3)

Company Name	Financing Status	Location	Employees	Last Financing Date/Type
CTI Clinical Trial & Consulting Services	Private Debt Financed	Covington, KY	0000	000000000 -
0000000000	Private Equity-Backed	Cuxhaven, Germany	00	000000000000
000000 000000	Corporation	Montreal, Canada

You’re viewing 3 of 3 competitors. Get the full list »

NuChem Sciences Patents

7
Total Documents Applications and Grants
000
Total Patents Families
000
Granted
000
Pending
000
Expiring in next 12 mo

NuChem Sciences Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)	Citations
CA-2984073-A1	Inhibitors of polynucleotide repeat-associated rna foci and uses thereof	Abandoned	27-Oct-2017	0000000000
AU-2014231330-A1	Small molecule modulators of pcsk9 and methods of use thereof	Abandoned	15-Mar-2013	0000000000
JP-2016511274-A	Pcsk9 small molecule modulator and method of use thereof	Pending	15-Mar-2013	0000000000	0
EP-2961765-A1	Small molecule modulators of pcsk9 and methods of use thereof	Withdrawn	15-Mar-2013	0000000000
CA-2905237-A1	Small molecule modulators of pcsk9 and methods of use thereof	Abandoned	15-Mar-2013	C07K5/0827

To view NuChem Sciences’s complete patent history, request access »

NuChem Sciences Executive Team (7)

Name	Title	Board Seat	Contact Info
Marc LeBel	Co-Owner, President & Chairman
Patrick Montpetit	Chief Financial Officer
Daniel Guay Ph.D	Co-Owner, Chief Scientific Officer & Executive Vice President
John Mancuso Ph.D	Co-Owner, Partner & Director
Marc Janes Ph.D	Co-Owner & Vice President of Business Development and Innovation